Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Giuseppe, Lucisano"'
Autor:
Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, Damiano Paolicelli, Emilio Portaccio, Matilde Inglese, Matteo Foschi, Francesco Patti, Franco Granella, Silvia Romano, Paola Cavalla, Giovanna De Luca, Paolo Gallo, Paolo Bellantonio, Antonio Gallo, Sara Montepietra, Alessia Di Sapio, Marika Vianello, Rocco Quatrale, Daniele Spitaleri, Raffaella Clerici, Valentina Torri Clerici, Eleonora Cocco, Vincenzo Brescia Morra, Girolama Alessandra Marfia, Vincenzo Daniele Boccia, Massimo Filippi, Maria Pia Amato, Maria Trojano, the Italian MS Register
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 8, Pp 2008-2015 (2024)
Abstract Objective No direct comparisons of the effect of natalizumab and ocrelizumab on progression independent of relapse activity (PIRA) and relapse‐associated worsening (RAW) events are currently available. We aimed to compare the risk of achie
Externí odkaz:
https://doaj.org/article/d5e45aa5f4bd4d6c8e2fa3b80816e126
Autor:
Rosaria Lombardo, Eric J. Beh, Francesco Prattichizzo, Giuseppe Lucisano, Antonio Nicolucci, Björn Eliasson, Hanne Krage Carlsen, Rosalba La Grotta, Valeria Pellegrini, Antonio Ceriello
Publikováno v:
Mathematics, Vol 12, Iss 14, p 2186 (2024)
Using data from the Swedish National Diabetes Register, this study examines the gender disparity among patients with type 1 diabetes who have experienced a specific cardiovascular complication, while exploring the association between their weight var
Externí odkaz:
https://doaj.org/article/295ffbeb71bd45c090d6a6715b50c6ad
Autor:
Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Chiara Frigé, Salvatore De Cosmo, Paolo Di Bartolo, Graziano Di Cianni, Paola Fioretto, Carlo Bruno Giorda, Roberto Pontremoli, Giuseppina Russo, Francesca Viazzi, Antonio Nicolucci
Publikováno v:
The Lancet Regional Health. Europe, Vol 31, Iss , Pp 100666- (2023)
Summary: Background: A delay in reaching HbA1c targets in patients with newly-diagnosed type 2 diabetes (T2D) is associated with an increased long-term risk of developing cardiovascular diseases (CVD), a phenomenon referred to as legacy effect. Wheth
Externí odkaz:
https://doaj.org/article/a09a0df5f22e4251b1cefbc1a04af825
Autor:
Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Stefan Franzén, Ann-Marie Svensson, Björn Eliasson, Antonio Nicolucci
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Background HbA1c variability has emerged as risk factor for cardiovascular diseases in diabetes. However, the impact of HbA1c variability on cardiovascular diseases in subjects within the recommended HbA1c target has been relatively unexplor
Externí odkaz:
https://doaj.org/article/d9562fba22564ae3b0d988e7ef5c6e15
Autor:
Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Björn Eliasson, Stefan Franzén, Ann-Marie Svensson, Antonio Nicolucci
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Background There is a high incidence of cardiovascular disease in diabetes. Weight variability has been reported as independent risk factor for cardiovascular disease in the general population and preliminarily also in people with type 2 dia
Externí odkaz:
https://doaj.org/article/6fe34fb5010c40f0a8a5df004d82b4e7
Autor:
Antonella Frattari, Vincenzo Savini, Ennio Polilli, Graziano Di Marco, Giuseppe Lucisano, Serena Corridoni, Tullio Spina, Alberto Costantini, Antonio Nicolucci, Paolo Fazii, Pierluigi Viale, Giustino Parruti
Publikováno v:
International Journal of Infectious Diseases, Vol 84, Iss , Pp 153-162 (2019)
Background: Gram-negative Multi-Drug-Resistant Organisms (GNMDROs) cause an increasing burden of disease in Intensive Care Units (ICUs). We deployed a multifaceted intervention to control selection and transmission of GNMDROs and to estimate at which
Externí odkaz:
https://doaj.org/article/d59fae62f1a5477caff49f2aac1aa33a
Autor:
Pietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, Damiano Paolicelli, Francesco Patti, Mauro Zaffaroni, Vincenzo Brescia Morra, Carlo Pozzilli, Giovanna De Luca, Matilde Inglese, Giuseppe Salemi, Giorgia Teresa Maniscalco, Eleonora Cocco, Patrizia Sola, Giacomo Lus, Antonella Conte, Maria Pia Amato, Franco Granella, Claudio Gasperini, Paolo Bellantonio, Rocco Totaro, Marco Rovaris, Marco Salvetti, Valentina Liliana Adriana Torri Clerici, Roberto Bergamaschi, Davide Maimone, Elio Scarpini, Marco Capobianco, Giancarlo Comi, Massimo Filippi, Maria Trojano
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background and aims: No consensus exists on how aggressively to treat relapsing–remitting multiple sclerosis (RRMS) nor on the timing of the treatment. The objective of this study was to evaluate disability trajectories in RRMS patients treated wit
Externí odkaz:
https://doaj.org/article/3703cb6bf10f4df8b43ccfba7b2d6c8a
Autor:
Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Stefan Franzén, Soffia Gudbjörnsdottir, Björn Eliasson, Antonio Nicolucci
Publikováno v:
European Journal of Preventive Cardiology. 30:719-727
Aims Cardiovascular risk factor control fluctuates, tends to change over time, and is potentially impacted by multifactorial interactions. Currently, the presence of risk factors, rather than their variability or interplay with one another, is taken
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::328bfe111eeb9ff3c854869b2e297b75
https://doi.org/10.1093/eurjpc/zwad072
https://doi.org/10.1093/eurjpc/zwad072
Autor:
Alessia Manni, Antonio Iaffaldano, Giuseppe Lucisano, Mariangela D'Onghia, Domenico Maria Mezzapesa, Vincenzo Felica, Pietro Iaffaldano, Maria Trojano, Damiano Paolicelli
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body
Externí odkaz:
https://doaj.org/article/54b0495983f247138d7789d79c943a87
Autor:
Lucia Ferrito, Barbara Predieri, Dorina Pjetraj, Maria Cristina Alessandrelli, Manuela Pagnini, Antonio Iannilli, Monica Marino, Stefano Tombolini, Basilio Pintaudi, Giuseppe Lucisano, Fabiana Zani, Lorenzo Iughetti, Antonio Nicolucci, Valentino Cherubini
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Diagnosis of type 1 diabetes (T1D) in a child is often associated with anger, denial, fear, and depression from the parents. The aim of the study was to improve parents’ adaptation to the diagnosis of diabetes of their child. Sixty-two parents (29
Externí odkaz:
https://doaj.org/article/a5727db2ffd84856a3fe04928ef3b344